IL6 is associated with response to dasatinib and cetuximab: Phase II clinical trial with mechanistic correlatives in cetuximab-resistant head and neck cancer
| Autor: | Stabile, L.P., Egloff, A.M., Gibson, M.K., Gooding, W.E., Ohr, J., Zhou, P., Rothenberger, N.J., Wang, L., Geiger, J.L., Flaherty, J.T., Grandis, J.R., Bauman, J.E. |
|---|---|
| Zdroj: | In Oral Oncology June 2017 69:38-45 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect